Based on the analysis of Neogen's profitability, liquidity, and operating efficiency, Neogen may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Neogen's Other Current Liabilities is most likely to increase significantly in the upcoming years. The Neogen's current Total Current Liabilities is estimated to increase to about 186.3 M, while Accumulated Other Comprehensive Income is forecasted to increase to (25.7 M). Key indicators impacting Neogen's financial strength include:
The essential information of the day-to-day investment outlook for Neogen includes many different criteria found on its balance sheet. An individual investor should monitor Neogen's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Neogen.
Neogen competes with Qiagen NV, Aclaris Therapeutics, IQVIA Holdings, Medpace Holdings, and ICON PLC. Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.
Comparative valuation techniques use various fundamental indicators to help in determining Neogen's current stock value. Our valuation model uses many indicators to compare Neogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neogen competition to find correlations between indicators driving Neogen's intrinsic value. More Info.
Neogen is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Neogen's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Neogen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Neogen Systematic Risk
Neogen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Neogen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Neogen correlated with the market. If Beta is less than 0 Neogen generally moves in the opposite direction as compared to the market. If Neogen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neogen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neogen is generally in the same direction as the market. If Beta > 1 Neogen moves generally in the same direction as, but more than the movement of the benchmark.
Neogen Thematic Clasifications
Neogen is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Neogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neogen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Neogen growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Neogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neogen based on widely used predictive technical indicators. In general, we focus on analyzing Neogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neogen's daily price indicators and compare them against related drivers.
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.